Publications

Export 34 results:
Author Title Type [ Year(Asc)]
Filters: Keyword is Psychiatric Status Rating Scales  [Clear All Filters]
2017
Als LC, Picouto MD, O'Donnell K, Nadel S, Cooper M, Pierce CM, Kramer T, Glover VAS, M Garralda E.  2017.  Stress hormones and posttraumatic stress symptoms following paediatric critical illness: an exploratory study.. Eur Child Adolesc Psychiatry. 26(5):511-519.
2016
Kedzior KKarolina, Gierke L, Gellersen HMarie, Berlim M.  2016.  Cognitive functioning and deep transcranial magnetic stimulation (DTMS) in major psychiatric disorders: A systematic review.. J Psychiatr Res. 75:107-15.
Emami S, Guimond S, M Chakravarty M, Lepage M.  2016.  Cortical thickness and low insight into symptoms in enduring schizophrenia.. Schizophr Res. 170(1):66-72.
Chung JKu, Plitman E, Nakajima S, M Chakravarty M, Caravaggio F, Takeuchi H, Gerretsen P, Iwata Y, Patel R, Mulsant BH et al..  2016.  Depressive Symptoms and Small Hippocampal Volume Accelerate the Progression to Dementia from Mild Cognitive Impairment.. J Alzheimers Dis. 49(3):743-54.
Ouellet-Morin I, Côté SM, Vitaro F, Hébert M, Carbonneau R, Lacourse É, Turecki G, Tremblay RE.  2016.  Effects of the MAOA gene and levels of exposure to violence on antisocial outcomes.. Br J Psychiatry. 208(1):42-8.
Florian H, Meier A, Gauthier S, Lipschitz S, Lin Y, Tang Q, Othman AA, Robieson WZ, Gault LM.  2016.  Efficacy and Safety of ABT-126 in Subjects with Mild-to-Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase Inhibitors: A Randomized, Double-Blind, Placebo-Controlled Study.. J Alzheimers Dis. 51(4):1237-47.
Gauthier S, Feldman HH, Schneider LS, Wilcock GK, Frisoni GB, Hardlund JH, Moebius HJ, Bentham P, Kook KA, Wischik DJ et al..  2016.  Efficacy and safety of tau-aggregation inhibitor therapy in patients with mild or moderate Alzheimer's disease: a randomised, controlled, double-blind, parallel-arm, phase 3 trial.. Lancet. 388(10062):2873-2884.
2015
Cummings J, Mintzer J, Brodaty H, Sano M, Banerjee S, Devanand DP, Gauthier S, Howard R, Lanctôt K, Lyketsos CG et al..  2015.  Agitation in cognitive disorders: International Psychogeriatric Association provisional consensus clinical and research definition.. Int Psychogeriatr. 27(1):7-17.
Barucker C, Sommer A, Beckmann G, Eravci M, Harmeier A, Schipke CG, Brockschnieder D, Dyrks T, Althoff V, Fraser PE et al..  2015.  Alzheimer amyloid peptide aβ42 regulates gene expression of transcription and growth factors.. J Alzheimers Dis. 44(2):613-24.
Buchy L, Hawco C, Joober R, Malla A, Lepage M.  2015.  Cognitive insight in first-episode schizophrenia: further evidence for a role of the ventrolateral prefrontal cortex.. Schizophr Res. 166(1-3):65-8.
Qiu A, Tuan TAnh, Ong MLyn, Li Y, Chen H, Rifkin-Graboi A, Broekman BFP, Kwek K, Saw S-M, Chong Y-S et al..  2015.  COMT haplotypes modulate associations of antenatal maternal anxiety and neonatal cortical morphology.. Am J Psychiatry. 172(2):163-72.
Ouellet J, McGirr A, Van den Eynde F, Jollant F, Lepage M, Berlim M.  2015.  Enhancing decision-making and cognitive impulse control with transcranial direct current stimulation (tDCS) applied over the orbitofrontal cortex (OFC): A randomized and sham-controlled exploratory study.. J Psychiatr Res. 69:27-34.
Gerretsen P, Menon M, M Chakravarty M, Lerch JP, Mamo DC, Remington G, Pollock BG, Graff-Guerrero A.  2015.  Illness denial in schizophrenia spectrum disorders: a function of left hemisphere dominance.. Hum Brain Mapp. 36(1):213-25.
Behdinan T, Foussias G, Wheeler AL, Stefanik L, Felsky D, Remington G, Rajji TK, M Chakravarty M, Voineskos AN.  2015.  Neuroimaging predictors of functional outcomes in schizophrenia at baseline and 6-month follow-up.. Schizophr Res. 169(1-3):69-75.
Shah JL, Tandon N, Howard ER, Mermon D, Miewald JM, Montrose DM, Keshavan MS.  2015.  Pituitary volume and clinical trajectory in young relatives at risk for schizophrenia.. Psychol Med. 45(13):2813-24.
Haro JMaria, Altamura C, Corral R, Elkis H, Evans J, Malla A, Krebs M-O, Zink M, Bernasconi C, Lalonde J et al..  2015.  Understanding the impact of persistent symptoms in schizophrenia: Cross-sectional findings from the Pattern study.. Schizophr Res. 169(1-3):234-40.
2014
Cherkasova MV, Faridi N, Casey KF, O'Driscoll GA, Hechtman L, Joober R, Baker GB, Palmer J, Dagher A, Leyton M et al..  2014.  Amphetamine-induced dopamine release and neurocognitive function in treatment-naive adults with ADHD.. Neuropsychopharmacology. 39(6):1498-507.
Benoit A, Bodnar M, Malla A, Joober R, Bherer L, Lepage M.  2014.  Changes in memory performance over a 12-month period in relation to achieving symptomatic remission after a first-episode psychosis.. Schizophr Res. 153(1-3):103-8.
Zarchi O, Diamond A, Weinberger R, Abbott D, Carmel M, Frisch A, Michaelovsky E, Gruber R, Green T, Weizman A et al..  2014.  A comparative study of the neuropsychiatric and neurocognitive phenotype in two microdeletion syndromes: velocardiofacial (22q11.2 deletion) and Williams (7q11.23 deletion) syndromes.. Eur Psychiatry. 29(4):203-10.
Fan Y, Herrera-Melendez ALucia, Pestke K, Feeser M, Aust S, Otte C, Pruessner JC, Böker H, Bajbouj M, Grimm S.  2014.  Early life stress modulates amygdala-prefrontal functional connectivity: implications for oxytocin effects.. Hum Brain Mapp. 35(10):5328-39.
Grimm S, Pestke K, Feeser M, Aust S, Weigand A, Wang J, Wingenfeld K, Pruessner JC, La Marca R, Böker H et al..  2014.  Early life stress modulates oxytocin effects on limbic system during acute psychosocial stress.. Soc Cogn Affect Neurosci. 9(11):1828-35.
Manchanda R, Norman R, Malla A, Harricharan R, Northcott S, Richard J.  2014.  Electroencephalographic abnormalities and 5-year outcome in first-episode psychosis.. Can J Psychiatry. 59(5):285-8.
Broekman BFP, Chan Y-H, Chong Y-S, Kwek K, Cohen SSharon, Haley CLouise, Chen H, Chee C, Rifkin-Graboi A, Gluckman PD et al..  2014.  The influence of anxiety and depressive symptoms during pregnancy on birth size.. Paediatr Perinat Epidemiol. 28(2):116-26.
Thaler L, Gauvin L, Joober R, Groleau P, de Guzman R, Ambalavanan A, Israel M, Wilson S, Steiger H.  2014.  Methylation of BDNF in women with bulimic eating syndromes: associations with childhood abuse and borderline personality disorder.. Prog Neuropsychopharmacol Biol Psychiatry. 54:43-9.
Groleau P, Joober R, Israel M, Zeramdini N, DeGuzman R, Steiger H.  2014.  Methylation of the dopamine D2 receptor (DRD2) gene promoter in women with a bulimia-spectrum disorder: associations with borderline personality disorder and exposure to childhood abuse.. J Psychiatr Res. 48(1):121-7.

Pages